JETEMA, Co., Ltd.
KOE: 216080.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jeong Sun Nam
- Employees
- 227
- Headquarters
- Wonju, South Korea
- IPO year
- 2019
- Market cap
- ₩232B
- Website
- http://www.jetema.com
Loading 216080…
Loading profile data…Frequently asked questions about 216080
What does JETEMA, Co., Ltd. (216080.KQ) do?
JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers botulinum toxins, fillers, anti-aging solutions, lifting threads for medical treatment, laser surgical instruments, and skin care hyaluronic acid masks. The company is headquartered in Wonju, South Korea.
Where does 216080.KQ trade?
JETEMA, Co., Ltd. (216080.KQ) trades on the KOSDAQ.
What sector is 216080.KQ in?
JETEMA, Co., Ltd. (216080.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of JETEMA, Co., Ltd.?
Jeong Sun Nam is the chief executive officer of JETEMA, Co., Ltd. (216080.KQ).
Where is JETEMA, Co., Ltd. headquartered?
JETEMA, Co., Ltd. is headquartered in South Korea.
Does 216080.KQ pay a dividend?
JETEMA, Co., Ltd. (216080.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 216080.KQ go public?
JETEMA, Co., Ltd. (216080.KQ) completed its initial public offering in 2019.